Aaron Welch Email & Phone Number
Biotech Equity Research Analyst @ ROTH Capital Partners (ROTH MKM)
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Aaron Welch Location
- United States
Aaron Welch Work
- Biotech Equity Research Analyst @ (September 2026 - Present)
- Co-Founder, Strategic Advisor @ Saber Therapeutics (September 2022 - Present)
- Investments Associate @ (July 2022 - July 2024)
- Director, Portfolio Strategy @ (June 2021 - September 2022)
- Director Business Analytics @ (June 2021 - September 2022)
- Equity Research Associate @ (December 2020 - June 2021)
- Equity Research Associate @ (March 2019 - December 2020)
- Assistant Professor @ (January 2013 - March 2019)
Aaron Welch Education
- The Johns Hopkins University
PhD (Cellular Biology)
2007-2012 - The University of Kansas
BS (Biochemistry)
2003-2006 - The Johns Hopkins University
Doctor of Philosophy (Molecular Biology)
- The University of Kansas
Bachelor of Science (Biochemistry)
- University of California, Berkeley
Post Doctoral Degree
Aaron Welch Skills
- Molecular Biology
- Cell Culture
- Western Blotting
- PCR
- Cell Biology
- Biochemistry
- Fluorescence Microscopy
- Protein Expression
- Confocal Microscopy
- Molecular Cloning
- Microscopy
- Genetics
- Tissue Culture
- qPCR
- Immunohistochemistry
- DNA
- Protein Chemistry
- ELISA
- RT-PCR
- Flow Cytometry
- ANOVA
- Attention to Detail
- Biodegradation
- Biotechnology
- Business Analysis Planning & Monitoring
- Buy-side
- CRISPR
- Cell Therapy
- Cellular Assays
- Clinical Study Design
- Collaborative R&D
- Competitive Analysis
- Coordination Of Projects
- DCF Valuation
- Data Analysis
- Due Diligence
- Embryology
- Equity Research
- Experimentation
- Federal & State Regulations
- Fermentation
- Financial Modeling
- Forecasting
- Gene Editing
- Genome Editing
- Grant Proposal Presentations
- Grant Writing
- Higher Education
- Intellectual Property
- Investment Advisory Services
- Investment Analysis
- Investment Portfolios
- Investment Research
- Laboratory Skills
- Licensing
- MCAT
- MIMO
- Machine Learning
- Machine Learning Algorithms
- Management of multi-disciplinary teams
- Market Research
- Microsoft Excel
- Microsoft Office
- Modifiers
- Molecular & Cellular Biology
- Mycotoxins
- NGS
- Non-Conforming
- Non-Executive Director
- Original Research
- Patent Preparation
- Pharmaceutical Research
- Pharmaceuticals
- Planning Budgeting & Forecasting
- Polymerase Chain Reaction (PCR)
- Private Investment
- Proposal Writing
- Public Speaking
- Rare Diseases
- Regenerative Medicine
- Regression Testing
- Regulatory Filings
- Research
- Revenue Forecasting
- Scientific Presentation
- Selenium
- Sensitivity Analysis
- Sequencing
- Statistical Data Analysis
- Strategic Planning
- Strategic Program Planning Process
- Target Identification
- Targeted Drug Delivery
- Teaching
- Technology Transfer
- Vectors
- Yeast two-hybrid
- Academic Research
- Consulting
- International
- Cell
- Life Sciences
- Polymerase Chain Reaction Pcr
- Fluorescence
- Yeast
- Strains
- Florida
- Rt Pcr
- Commercial Applications
- Polymerase Chain Reaction
Aaron Welch Summary
- Aaron Welch, based in United States, is currently a Biotech Equity Research Analyst at ROTH Capital Partners. Aaron Welch brings experience from previous roles at Saber Therapeutics, SymBiosis and Cytovia Therapeutics. Aaron Welch holds a 2007 - 2012 PhD in Cellular Biology @ The Johns Hopkins University. With a robust skill set that includes Molecular Biology, Cell Culture, Western Blotting, PCR, Cell Biology and more. Aaron Welch has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Aaron Welch?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co